Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Second Trimester Maternal Serum Homocysteine Level & Uterine Artery Doppler for Prediction of Preeclampsia , Intra-Uterine Growth Retardation (IUGR) & Other Obstetric Complications

NCT02541110 is registered in ClinicalTrials.gov with Kasr El Aini Hospital as lead sponsor.

NCT NCT02541110
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02541110 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Second Trimester Maternal Serum Homocysteine Level & Uterine Artery Doppler for Prediction of Preeclampsia , Intra-Uterine Growth Retardation (IUGR) & Other Obstetric Complications
Lead sponsor
Kasr El Aini Hospital
Phase
Observational
Overall status
Unknown status
Start date
September 30, 2015
Completion date
February 29, 2016
Enrollment
200 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

iugr, preeclampsia